Literature DB >> 25082905

Should we exercise caution with benzodiazepine use in patients with COPD?

Robert Rodriguez-Roisin1, Judith Garcia-Aymerich2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25082905     DOI： 10.1183/09031936.00071014

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  4 in total

Review 1.  Benzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases in adults.

Authors:  Steffen T Simon; Irene J Higginson; Sara Booth; Richard Harding; Vera Weingärtner; Claudia Bausewein
Journal:  Cochrane Database Syst Rev       Date:  2016-10-20

2.  Substance Use and Misuse among Adults with Chronic Obstructive Pulmonary Disease in the United States, 2015-2019: Prevalence, Association, and Moderation.

Authors:  Abdullah M M Alanazi; Mohammed M Alqahtani; Maher M Alquaimi; Tareq F Alotaibi; Saleh S Algarni; Taha T Ismaeil; Ahmad A Alanazi; Moudi M Alasmari; Eyas A Alhuthail; Ali M Alasmari; Linda Gibson-Young; Wasantha P Jayawardene
Journal:  Int J Environ Res Public Health       Date:  2021-12-31       Impact factor: 3.390

Review 3.  Benzodiazepines and Z-Drugs: An Updated Review of Major Adverse Outcomes Reported on in Epidemiologic Research.

Authors:  Jaden Brandt; Christine Leong
Journal:  Drugs R D       Date:  2017-12

4.  Risk of long-term benzodiazepine and Z-drug use following the first prescription among community-dwelling adults with anxiety/mood and sleep disorders: a retrospective cohort study.

Authors:  Jaden Brandt; Donica Janzen; Silvia Alessi-Severini; Alexander Singer; Dan Chateau; Murray Enns; Christine Leong
Journal:  BMJ Open       Date:  2021-11-01       Impact factor: 2.692
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.